Sana Biotechnology, Inc. (SANA)
2.89
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
2.90
+0.01
(+0.35%)
After-Hours: 20:00
Sana Biotechnology EPS Diluted (Quarterly) : -0.2152 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2152 |
| March 31, 2026 | -0.1705 |
| December 31, 2025 | -0.2132 |
| September 30, 2025 | -0.1618 |
| June 30, 2025 | -0.3934 |
| March 31, 2025 | -0.2079 |
| December 31, 2024 | -0.2077 |
| September 30, 2024 | -0.2546 |
| June 30, 2024 | -0.2145 |
| March 31, 2024 | -0.4946 |
| December 31, 2023 | -0.4466 |
| September 30, 2023 | 0.0049 |
| June 30, 2023 | -0.5921 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4294 |
| December 31, 2022 | -0.4224 |
| September 30, 2022 | -0.4496 |
| June 30, 2022 | -0.3862 |
| March 31, 2022 | -0.1691 |
| December 31, 2021 | -0.6018 |
| September 30, 2021 | -0.4579 |
| June 30, 2021 | 0.0981 |
| March 31, 2021 | -1.516 |
| December 31, 2020 | -0.6036 |
| March 31, 2020 | -3.038 |
| December 31, 2019 | -0.2298 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.7989 |
| Twist Bioscience Corp. | -0.5617 |
| Beam Therapeutics, Inc. | -1.176 |
| Prime Medicine, Inc. | -0.2376 |
| Revolution Medicines, Inc. | -3.055 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -63.64M |
| Total Expenses (Quarterly) | 63.64M |
| Enterprise Value | 774.05M |
| Earnings Yield | -26.32% |
| Normalized Earnings Yield | -23.48 |